Pharmaceuticals, Biotechnology and Life Sciences
PARIS–(BUSINESS WIRE)–Genethon, a non-profit research organization focused on developing gene therapies for rare diseases, today marks International Rare Disease Day…
MONTPELLIER, France–(BUSINESS WIRE)–Regulatory News: Sensorion (FR0012596468 – ALSEN) a pioneering clinical-stage biotechnology company which specializes in the development of novel…
OLDSMAR, Fla.–(BUSINESS WIRE)–Cryo-Cell International, Inc. (NYSE American LLC: CCEL) (the “Company”), the world’s first private cord blood bank to separate…
– Net product revenues for the fourth quarter 2023 totaled $365.1 million, a 55% increase over the same quarter of…
– Q4 and full year 2023 product revenue (DAXXIFY® and RHA® Collection) of $58.5 million and $212.7 million, representing approximately…
Full-year 2023 revenue of $220 million, an increase of 60% compared to 2022 and above previously reported guidance Delivered 70,429…
– Net product sales totaled $178.9 million, and full year 2023 revenue totaled $186.4 million, delivering 142% growth over 2022…
FREMONT, Calif.–(BUSINESS WIRE)–Personalis, Inc. (Nasdaq: PSNL), a leader in advanced genomics for precision oncology, today reported financial results for the…
SOUTH SAN FRANCISCO, Calif.–(BUSINESS WIRE)–Kezar Life Sciences, Inc. (Nasdaq: KZR), a clinical-stage biotechnology company developing breakthrough treatments for immune-mediated and…
RICHMOND, Va.–(BUSINESS WIRE)–Blue Heron Capital, an early-stage growth equity firm, is excited to announce its investment in Redi Health, a…